Literature DB >> 19766402

Regulation of cortical and hippocampal 5-HT(1A) receptor function by corticosterone in GR+/- mice.

Julie G Hensler1, Miriam A Vogt, Peter Gass.   

Abstract

Our objective in the present study was to examine 5-HT(1A) receptor function in prefrontal cortex and hippocampus of GR+/- mice, which appear to be an appropriate murine model of depression. 5-HT(1A) receptor function was determined by measuring [(35)S]GTPgammaS binding stimulated by the 5-HT(1A) receptor agonist 8-OH-DPAT (1 microM), an indication of the capacity of the receptor to activate G proteins. 5-HT(1A) receptor expression was determined by measuring the binding of [(3)H]8-OH-DPAT (2 nM). We observed no effect of the constitutive reduction in GR on 5-HT(1A) receptor-stimulated [(35)S]GTPgammaS binding or 5-HT(1A) receptor binding sites. Corticosterone treatment (10mg/kg, sc once daily for 21 days) of wild-type mice resulted in a decrease in 5-HT(1A) receptor function in prefrontal cortex [8-OH-DPAT-stimulated [(35)S]GTPgammaS binding (% above basal), vehicle-treated: 39+/-4.9; corticosterone-treated: 17+/-2.8], but not in hippocampus. The constitutive reduction in GR expression prevented the down-regulation of 5-HT(1A) receptor function in frontal cortex by chronic corticosterone administration. In contrast, corticosterone treatment of GR+/- mice resulted in an increase in 5-HT(1A) receptor function in hippocampus which reached statistical significance in CA2/3 region [8-OH-DPAT-stimulated [(35)S]GTPgammaS binding (% above basal), vehicle-treated: 41+/-9.7; corticosterone-treated: 94+/-23]. These changes seem to be evoked by a combined effect of high corticosterone levels and GR deficiency. Although GR+/- mice do not exhibit changes in baseline corticosterone, the constitutive deficiency in GR appears to have unmasked regulatory effects of elevated corticosterone in the maintenance of 5-HT(1A) receptor function in prefrontal cortex and hippocampus. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19766402      PMCID: PMC3816533          DOI: 10.1016/j.psyneuen.2009.08.015

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  17 in total

Review 1.  The corticosteroid receptor hypothesis of depression.

Authors:  F Holsboer
Journal:  Neuropsychopharmacology       Date:  2000-11       Impact factor: 7.853

Review 2.  Stress and plasticity in the limbic system.

Authors:  Robert M Sapolsky
Journal:  Neurochem Res       Date:  2003-11       Impact factor: 3.996

3.  A role for the mineralocorticoid receptor in a rapid and transient suppression of hippocampal 5-HT1A receptor mRNA by corticosterone.

Authors:  O C Meijer; E R de Kloet
Journal:  J Neuroendocrinol       Date:  1995-08       Impact factor: 3.627

4.  Elevated basal trough levels of corticosterone suppress hippocampal 5-hydroxytryptamine(1A) receptor expression in adrenally intact rats: implication for the pathogenesis of depression.

Authors:  O C Meijer; R V Van Oosten; E R De Kloet
Journal:  Neuroscience       Date:  1997-09       Impact factor: 3.590

5.  Effects of adrenalectomy and type I or type II glucocorticoid receptor activation on 5-HT1A and 5-HT2 receptor binding and 5-HT transporter mRNA expression in rat brain.

Authors:  Y Kuroda; Y Watanabe; D S Albeck; N B Hastings; B S McEwen
Journal:  Brain Res       Date:  1994-06-13       Impact factor: 3.252

6.  A quantitative autoradiographic study of serotonin1A receptor regulation. Effect of 5,7-dihydroxytryptamine and antidepressant treatments.

Authors:  J G Hensler; G B Kovachich; A Frazer
Journal:  Neuropsychopharmacology       Date:  1991-02       Impact factor: 7.853

7.  Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions.

Authors:  Stephanie Ridder; Sabine Chourbaji; Rainer Hellweg; Alexandre Urani; Christiane Zacher; Wolfgang Schmid; Mathias Zink; Heide Hörtnagl; Herta Flor; Fritz A Henn; Günther Schütz; Peter Gass
Journal:  J Neurosci       Date:  2005-06-29       Impact factor: 6.167

8.  Modulation of 5HT1A responsiveness in CA1 pyramidal neurons by in vivo activation of corticosteroid receptors.

Authors:  W Hesen; M Joëls
Journal:  J Neuroendocrinol       Date:  1996-06       Impact factor: 3.627

Review 9.  Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness.

Authors:  James P Herman; Helmer Figueiredo; Nancy K Mueller; Yvonne Ulrich-Lai; Michelle M Ostrander; Dennis C Choi; William E Cullinan
Journal:  Front Neuroendocrinol       Date:  2003-07       Impact factor: 8.606

10.  Activation of glucocorticoid receptors increases 5-HT2A receptor levels.

Authors:  Viktorija Trajkovska; Lisbeth Kirkegaard; Gesa Krey; Anders B Marcussen; Morten S Thomsen; Sabine Chourbaji; Christiane Brandwein; Stephanie Ridder; Christer Halldin; Peter Gass; Gitte M Knudsen; Susana Aznar
Journal:  Exp Neurol       Date:  2009-04-18       Impact factor: 5.330

View more
  5 in total

1.  Enhanced novelty-induced corticosterone spike and upregulated serotonin 5-HT1A and cannabinoid CB1 receptors in adolescent BTBR mice.

Authors:  Georgianna G Gould; Teresa F Burke; Miguel D Osorio; Corey M Smolik; Wynne Q Zhang; Emmanuel S Onaivi; Ting-Ting Gu; Mauris N DeSilva; Julie G Hensler
Journal:  Psychoneuroendocrinology       Date:  2013-09-12       Impact factor: 4.905

2.  Treatment of depressive-like behaviour in Huntington's disease mice by chronic sertraline and exercise.

Authors:  Thibault Renoir; Terence Y C Pang; Michelle S Zajac; Grace Chan; Xin Du; Leah Leang; Caroline Chevarin; Laurence Lanfumey; Anthony J Hannan
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  Plasticity of presynaptic and postsynaptic serotonin 1A receptors in an animal model of epilepsy-associated depression.

Authors:  Eduardo A Pineda; Julie G Hensler; Raman Sankar; Don Shin; Teresa F Burke; Andréy M Mazarati
Journal:  Neuropsychopharmacology       Date:  2011-02-23       Impact factor: 7.853

4.  Repeated administration of the 5-HT₁B/₁A agonist, RU 24969, facilitates the acquisition of MDMA self-administration: role of 5-HT₁A and 5-HT₁B receptor mechanisms.

Authors:  Dane Aronsen; Natasha Bukholt; Susan Schenk
Journal:  Psychopharmacology (Berl)       Date:  2016-02-09       Impact factor: 4.530

5.  Glucocorticoid receptor and FKBP5 expression is altered following exposure to chronic stress: modulation by antidepressant treatment.

Authors:  Gianluigi Guidotti; Francesca Calabrese; Christoph Anacker; Giorgio Racagni; Carmine M Pariante; Marco A Riva
Journal:  Neuropsychopharmacology       Date:  2012-11-21       Impact factor: 7.853

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.